Literature DB >> 33855352

Biallelic variants in LIG3 cause a novel mitochondrial neurogastrointestinal encephalomyopathy.

Elena Bonora1, Sanjiban Chakrabarty2, Georgios Kellaris3, Makiko Tsutsumi4, Francesca Bianco1, Christian Bergamini5, Farid Ullah3, Federica Isidori1, Irene Liparulo5, Chiara Diquigiovanni1, Luca Masin5, Nicola Rizzardi5, Mariapia Giuditta Cratere1,6, Elisa Boschetti1, Valentina Papa7, Alessandra Maresca8, Giovanna Cenacchi7, Rita Casadio9, Pierluigi Martelli9, Ivana Matera10, Isabella Ceccherini10, Romana Fato5, Giuseppe Raiola11, Serena Arrigo10, Sara Signa10, Angela Rita Sementa10, Mariasavina Severino10, Pasquale Striano10, Chiara Fiorillo10, Tsuyoshi Goto12, Shumpei Uchino13,14, Yoshinobu Oyazato15, Hisayoshi Nakamura16, Sushil K Mishra17, Yu-Sheng Yeh12, Takema Kato4, Kandai Nozu18, Jantima Tanboon16, Ichiro Morioka19, Ichizo Nishino16, Tatsushi Toda20, Yu-Ichi Goto21, Akira Ohtake22, Kenjiro Kosaki23, Yoshiki Yamaguchi24, Ikuya Nonaka16, Kazumoto Iijima18, Masakazu Mimaki13, Hiroki Kurahashi4, Anja Raams2, Alyson MacInnes25, Mariel Alders26, Marc Engelen27, Gabor Linthorst25, Tom de Koning28, Wilfred den Dunnen29, Gerard Dijkstra30, Karin van Spaendonck26, Dik C van Gent2, Eleonora M Aronica31, Paolo Picco10, Valerio Carelli7,8, Marco Seri1, Nicholas Katsanis3, Floor A M Duijkers26, Mariko Taniguchi-Ikeda4,18,32, Roberto De Giorgio33.   

Abstract

Abnormal gut motility is a feature of several mitochondrial encephalomyopathies, and mutations in genes such as TYMP and POLG, have been linked to these rare diseases. The human genome encodes three DNA ligases, of which only one, ligase III (LIG3), has a mitochondrial splice variant and is crucial for mitochondrial health. We investigated the effect of reduced LIG3 activity and resulting mitochondrial dysfunction in seven patients from three independent families, who showed the common occurrence of gut dysmotility and neurological manifestations reminiscent of mitochondrial neurogastrointestinal encephalomyopathy. DNA from these patients was subjected to whole exome sequencing. In all patients, compound heterozygous variants in a new disease gene, LIG3, were identified. All variants were predicted to have a damaging effect on the protein. The LIG3 gene encodes the only mitochondrial DNA (mtDNA) ligase and therefore plays a pivotal role in mtDNA repair and replication. In vitro assays in patient-derived cells showed a decrease in LIG3 protein levels and ligase activity. We demonstrated that the LIG3 gene defects affect mtDNA maintenance, leading to mtDNA depletion without the accumulation of multiple deletions as observed in other mitochondrial disorders. This mitochondrial dysfunction is likely to cause the phenotypes observed in these patients. The most prominent and consistent clinical signs were severe gut dysmotility and neurological abnormalities, including leukoencephalopathy, epilepsy, migraine, stroke-like episodes, and neurogenic bladder. A decrease in the number of myenteric neurons, and increased fibrosis and elastin levels were the most prominent changes in the gut. Cytochrome c oxidase (COX) deficient fibres in skeletal muscle were also observed. Disruption of lig3 in zebrafish reproduced the brain alterations and impaired gut transit in vivo. In conclusion, we identified variants in the LIG3 gene that result in a mitochondrial disease characterized by predominant gut dysmotility, encephalopathy, and neuromuscular abnormalities. Bonora et al. identify a new mitochondrial recessive disorder caused by biallelic variants in the LIG3 gene encoding DNA ligase III, which is responsible for mitochondrial DNA repair. Clinical signs include gut dysmotility and neurological features such as leucoencephalopathy, epilepsy and stroke-like episodes.
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 LIG3zzm321990 ; CIPO; MNGIE; mtDNA repair; mtDNA replication

Year:  2021        PMID: 33855352     DOI: 10.1093/brain/awab056

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  10 in total

1.  Mitochondrial DNA Copy Number as a Marker and Mediator of Stroke Prognosis: Observational and Mendelian Randomization Analyses.

Authors:  Michael Robert Chong; Sukrit Narula; Robert Morton; Conor Judge; Loubna Akhabir; Nathan Cawte; Nazia Pathan; Ricky Lali; Pedrum Mohammadi-Shemirani; Ashkan Shoamanesh; Martin O'Donnell; Salim Yusuf; Peter Langhorne; Guillaume Paré
Journal:  Neurology       Date:  2021-12-08       Impact factor: 9.910

Review 2.  Mitochondrial DNA damage as driver of cellular outcomes.

Authors:  Cristina A Nadalutti; Sylvette Ayala-Peña; Janine H Santos
Journal:  Am J Physiol Cell Physiol       Date:  2021-12-22       Impact factor: 4.249

Review 3.  Clinical genetics of Charcot-Marie-Tooth disease.

Authors:  Yujiro Higuchi; Hiroshi Takashima
Journal:  J Hum Genet       Date:  2022-03-18       Impact factor: 3.755

4.  Comment to the Description of a Novel Cohesinopathy in Chronic Intestinal Pseudo Obstruction.

Authors:  Elena Bonora; Francesca Bianco; Roberto De Giorgio
Journal:  J Neurogastroenterol Motil       Date:  2022-07-30       Impact factor: 4.725

Review 5.  Mitochondrial Retinopathies.

Authors:  Massimo Zeviani; Valerio Carelli
Journal:  Int J Mol Sci       Date:  2021-12-25       Impact factor: 5.923

6.  Myopathic mitochondrial DNA depletion syndrome associated with biallelic variants in LIG3.

Authors:  Federica Invernizzi; Andrea Legati; Alessia Nasca; Eleonora Lamantea; Barbara Garavaglia; Mirjana Gusic; Robert Kopajtich; Holger Prokisch; Massimo Zeviani; Costanza Lamperti; Daniele Ghezzi
Journal:  Brain       Date:  2021-10-22       Impact factor: 15.255

Review 7.  Novel understanding on genetic mechanisms of enteric neuropathies leading to severe gut dysmotility.

Authors:  Francesca Bianco; Giulia Lattanzio; Luca Lorenzini; Chiara Diquigiovanni; Maurizio Mazzoni; Paolo Clavenzani; Laura Calzà; Luciana Giardino; Catia Sternini; Elena Bonora; Roberto De Giorgio
Journal:  Eur J Histochem       Date:  2021-11-25       Impact factor: 3.188

Review 8.  Mitochondrial Neurodegeneration.

Authors:  Massimo Zeviani; Carlo Viscomi
Journal:  Cells       Date:  2022-02-11       Impact factor: 6.600

9.  Selective targeting BMP2 and 4 in SMAD4 negative esophageal adenocarcinoma inhibits tumor growth and aggressiveness in preclinical models.

Authors:  Shulin Li; Sanne J M Hoefnagel; Matthew Read; Sybren Meijer; Mark I van Berge Henegouwen; Suzanne S Gisbertz; Elena Bonora; David S H Liu; Wayne A Phillips; Silvia Calpe; Ana C P Correia; Maria D C Sancho-Serra; Sandro Mattioli; Kausilia K Krishnadath
Journal:  Cell Oncol (Dordr)       Date:  2022-07-28       Impact factor: 7.051

10.  Common methods in mitochondrial research (Review).

Authors:  Yiyuan Yin; Haitao Shen
Journal:  Int J Mol Med       Date:  2022-08-25       Impact factor: 5.314

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.